Trial document




drksid header

  DRKS00012823

Trial Description

start of 1:1-Block title

Title

Short-term, long-term and cost-effectiveness of treating depression and anxiety disorders in children and adolescents – a randomized controlled trial.

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

[---]*

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

The current study will evaluate and compare the effectiveness of cognitive-behavioral and psychodynamic therapy. Therefore 420 children and adolescents (ages 8-16 years) with depression and/or anxiety disorder will be randomly assigned to a treatment or a control condition. The intervention´s short-term effectiveness and sustainability as well as cost-effectiveness will be examined over a 5 year period for each participant.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language


This study aims to optimize patient-centered care and to ensure scientific and legal approval of cognitive-behavioral and psychodynamic therapy for children and adolescents in the German health-care system. This prospective, randomized and controlled trial compares psychodynamic and cognitive behavioral therapy for children and adolescents with depression and anxiety disorder.

Number of diagnoses or fulfilled diagnostic criteria - diagnosed by a trained psychologist who is blind for treatment condition as well as rated by patients and parents - will be the primary outcome. Secondary outcomes are patients´ and parents´ subjective burden caused by the child's symptoms, patients´ quality of life, individual and family functioning and treatments´ cost effectiveness.

Patients are recruited in child and adolescent psychiatries in Hamburg.

After gathering informed consent from parents and patients, the latter will be randomly assigned to either psychodynamic therpy or CBT. Both interventions are based on manuals.
Data will be collected annually over a period of five years starting at the beginning of treatment. This allows examination of varying treatment intervals as well as long-term and cost-effectiveness ot the interventions.

To analyze data, comparisons of means will be performed. Groupwise analyses of interaction will be performed for inferential testing of differences in subgroups. Differences in therapy effects will be inferentially analyzed by multifactor analysis of covariance, analysis of variance or logistic regression. Interaction effects and predicting variables are of special interest.

In a Subsample of 32 depressive adolescents (ages 13-16) patients expectations before and experiences whilst therapy will be analyzed by a mixed-methods-approach.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00012823
  •   2017/09/27
  •   [---]*
  •   yes
  •   Approved
  •   PV5560, Ethik-Kommission der Ärztekammer Hamburg
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  •   U1111-1202-1831 
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   F30-F39 -  Mood [affective] disorders
  •   F40 -  Phobic anxiety disorders
  •   F41 -  Other anxiety disorders
  •   F42 -  Obsessive-compulsive disorder
  •   Depression and/or anxiety disorder
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   outpatient psychodynamic psychothrapy in single patient setting, therapy frequnency and duration depend on indication
  •   oupatient cognitive behavioral therapy in single patient setting, therapy frequnency and duration depend on indication
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Blinded
  •   assessor
  •   Active control (effective treament of control group)
  •   Treatment
  •   Parallel
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Number of psychiatric diagnoses respectively number of diagnostic criteria will be assessed by Kiddie-SADS interview (Delmo et al., 2001). The Kiddie-SADS interview will be conducted by a trained rater external to the project before treatment henceforth annually over a 5 year period for each child.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Children´s depressive symptomatology will be assessed by children´s (aged 10 years and older) and parents´ rating of the german version of the "Children´s depression inventory" (Depressionsinventar für Kinder und Jugendliche (DIKJ;
Stiensmeier-Pelster, Schürmann, & Duda, 2000) before therapy starts and henceforth annually over a five year period.
Children´s anxiety symptomatology will be assessed by children´s (aged 10 years and older) and parents´ rating of the german version of the "Screen for child anxiety related emotional disorders" (Scared; Birmaher, Khetarpal, Cully, Brent, & McCanzie, 1995) before therapy starts and henceforth annually over a five year period.
Cildren´s psychiatric disorders will further be assessed by parents´ rating of the german version of the "Child behavior checklist" (CBCL; Achenbach, 1991) before therapy starts and henceforth annually over a five year period.
Cildren´s psychiatric disorders will further be assessed by children´s (aged 10 years and older) rating of the german version of the "Youth self report" (YSR; Achenbach, 1991) before therapy starts and henceforth annually over a five year period.
Children´s structural functioning will be assessed by self-report (children and adolescents aged 10 years and older) using the german structure questionnaire for the "Operationalized psychodynamic diagnostic for children and adolescents" (OPD-KJ2-SF, Schrobildgen et al., 2017) before therapy starts and henceforth annually over a five year period.
Children´s health related quality of life will be assessed by children´s (aged 10 years and older) and parents´ rating of the german version of the Kidscreen (Ravens-Sieberer & the European KIDSCREEN group, 2006) before therapy starts and henceforth annually over a five year period.
Children´s global impairment will be assessed by a trained rater external to the project using the german "Skala zur Gesamtbeurteilung von Kindern und Jugendlichen" (SGKJ; Steinhausen, 1985) before therapy starts and henceforth annually over a five year period.
Families´ relational functioning will be rated by a trained rater external to the project using the german version of the "Global assessment of relational functioning scale" (GARF; Saß, Wittchen, & Zaudig, 1996) before therapy starts and henceforth annually over a five year period.
Children´s global functioning will be rated by a trained rater external to the project using the german version of the "Global assessment functioning scale" (GAF; American Psychiatric Association, 2000) before therapy starts and henceforth annually over a five year period.
Health economics will be assessed by a trained rater external to the project using the german version of the "Children and adolescent mental health services receipt inventory" (CAMHSRI-EU; Kilian et al., 2009) before therapy starts and henceforth annually over a five year period.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
  • University Medical Center 
  • Medical Center 
  • Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2018/07/26
  •   420
  •   Multicenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   6   Years
  •   18   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

diagnosis of a depressive disorder (ICD-10; F30-F39) or an anxiety
disorder (ICD-10; F40-F42)
informed consent (patients and parents)

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

psychotic disorders, eating disorders, substance use related disorders (except caffeine and nicotine), autism spectrum disorders, mutism,
personality disorders
neurologic disorders
severe mental retardation (filling out questionnaires and interview are not feasible)
low command of the german language

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Universitätsklinikum Hamburg-Eppendorf
    • Ms.  Prof. Dr.  Silke  Wiegand-Grefe 
    • Martinistraße 52
    • 20246  Hamburg
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Universitätsklinikum Hamburg-Grefe
    • Ms.  Prof. Dr.  Silke  Wiegand-Grefe 
    • Martinistr. 52
    • 20246  Hamburg
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Universitätsklinikum Hamburg-Eppendorf
    • Ms.  Prof. Dr.  Silke  Wiegand-Grefe 
    • Martinistraße 52
    • 20246  Hamburg
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Vereinigung Analytischer Kinder- und Jugendlichen-Psychotherapeuten in Deutschland e.V (VAKJP)
    • Kurfürstendamm 72
    • 10709  Berlin
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.